Editas Medicine announced proof-of-concept data for a gene-editing approach for sickle cell disease that doesn't need a stem ...

An unfortunate reality is that life costs more when you are disabled. Why is this? Simply put, living with a disability often ...

Columnist and caregiver Sylvia Amuta shares the top pain management strategies that help her young cousin cope with sickle ...

Enrollment has finished for the Phase 3 RISE UP study, which is testing the oral therapy mitapivat in people with sickle cell ...

The FDA granted orphan drug status to Kind Pharmaceuticals' investigational oral small molecule AND017 to treat SCD.

Approved in India as Oxemia for anemia, desidustat stimulates erythropoietin, a signaling molecule secreted in response to ...

Note: This column describes the author’s own experiences with various medications, including nonsteroidal anti-inflammatory drugs and oral opioids. Not everyone will have the same response to ...